Literature DB >> 12920329

Depressive symptoms lead to impaired cellular immune response.

Cristina Fortes1, Sara Farchi, Francesco Forastiere, Nera Agabiti, Roberta Pacifici, Piergiorgio Zuccaro, Carlo A Perucci, Shah Ebrahim.   

Abstract

BACKGROUND: The association between depression and immune response is not yet clear. The biological mechanisms by which depression alters the immune system is not yet understood. The purpose of this study was to investigate the longitudinal relationship between depressive symptoms and cellular immune response.
METHODS: A cohort study with a baseline measurement and three annual health assessments was set up in a residential home for elderly people in Rome, Italy. A total of 166 residents aged 65 years and older, mean age 81 years, were interviewed and blood samples were collected at each annual assessment. Percentage changes in lymphocytes and T-cell subsets related to depressive symptoms were estimated over a period of 4 years, using regression models for repeated measurements.
RESULTS: Elderly people with seven or more symptoms of depression, according to the Geriatric Depression Scale, had a lower percentage of CD4+DR+ T-cells over 4 years [beta = -20.2; 95% confidence interval (CI) = -33.0 to -4.9] and CD8+DR+ T-cells (beta = -26.9; 95% CI = -42.5 to -7.0) than elderly with less than seven symptoms of depression, after adjusting for confounding factors (sex, age, marital status, education, smoking habit, nutritional status, chronic diseases, disability and the use of benzodiazepines).
CONCLUSION: The results of this study suggest an adverse effect of depressive symptoms on immune response. It remains to be determined whether these depression-associated immune changes are related to the onset or course of physical illness and the increased mortality observed in depressed old people. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920329     DOI: 10.1159/000071896

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  5 in total

1.  Antidepressant medication use before and after kidney transplant: implications for outcomes - a retrospective study.

Authors:  Krista L Lentine; Abhijit S Naik; Rosemary Ouseph; Zidong Zhang; David A Axelrod; Dorry L Segev; Vikas R Dharnidharka; Daniel C Brennan; Henry Randall; Raj Gadi; Ngan N Lam; Gregory P Hess; Bertram L Kasiske; Mark A Schnitzler
Journal:  Transpl Int       Date:  2017-08-03       Impact factor: 3.782

Review 2.  Psychological stress in IBD: new insights into pathogenic and therapeutic implications.

Authors:  J E Mawdsley; D S Rampton
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

3.  Prevalence and risk factors for chalazion in an older veteran population.

Authors:  Sneh Patel; Natalia Tohme; Emmanuel Gorrin; Naresh Kumar; Brian Goldhagen; Anat Galor
Journal:  Br J Ophthalmol       Date:  2021-03-31       Impact factor: 5.908

4.  Shen-Qi-Jie-Yu-Fang has antidepressant effects in a rodent model of postpartum depression by regulating the immune organs and subsets of T lymphocytes.

Authors:  Miao Qu; Qisheng Tang; Xiaoli Li; Ruizhen Zhao; Jingya Li; Hong Xu; Yushan Gao; Yingqiu Mao
Journal:  Neuropsychiatr Dis Treat       Date:  2015-06-25       Impact factor: 2.570

5.  Prevalence of depressive symptoms and factors associated with it in type 2 diabetic patients: a cross-sectional study in China.

Authors:  Linchuang Wang; Rui Song; Zhigang Chen; Jun Wang; Feng Ling
Journal:  BMC Public Health       Date:  2015-02-25       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.